1. Home
  2. XBIO vs DGLY Comparison

XBIO vs DGLY Comparison

Compare XBIO & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • DGLY
  • Stock Information
  • Founded
  • XBIO N/A
  • DGLY 2004
  • Country
  • XBIO United States
  • DGLY United States
  • Employees
  • XBIO N/A
  • DGLY N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • XBIO Health Care
  • DGLY Technology
  • Exchange
  • XBIO Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • XBIO 4.9M
  • DGLY 3.9M
  • IPO Year
  • XBIO N/A
  • DGLY N/A
  • Fundamental
  • Price
  • XBIO $2.99
  • DGLY $1.78
  • Analyst Decision
  • XBIO Hold
  • DGLY
  • Analyst Count
  • XBIO 1
  • DGLY 0
  • Target Price
  • XBIO N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • XBIO 47.7K
  • DGLY 91.3K
  • Earning Date
  • XBIO 08-13-2025
  • DGLY 08-22-2025
  • Dividend Yield
  • XBIO N/A
  • DGLY N/A
  • EPS Growth
  • XBIO N/A
  • DGLY N/A
  • EPS
  • XBIO N/A
  • DGLY N/A
  • Revenue
  • XBIO $2,446,221.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • XBIO $10.15
  • DGLY N/A
  • Revenue Next Year
  • XBIO $11.11
  • DGLY N/A
  • P/E Ratio
  • XBIO N/A
  • DGLY N/A
  • Revenue Growth
  • XBIO N/A
  • DGLY N/A
  • 52 Week Low
  • XBIO $2.20
  • DGLY $1.73
  • 52 Week High
  • XBIO $5.27
  • DGLY $183.00
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 30.59
  • DGLY 25.67
  • Support Level
  • XBIO $2.63
  • DGLY $1.73
  • Resistance Level
  • XBIO $3.26
  • DGLY $2.03
  • Average True Range (ATR)
  • XBIO 0.21
  • DGLY 0.09
  • MACD
  • XBIO -0.08
  • DGLY 0.17
  • Stochastic Oscillator
  • XBIO 8.17
  • DGLY 15.15

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: